Component
3-S-Glutathionylacetaminophen
3-S-Glutathionylacetaminophen. Species, exposure and limitations are retained in each linked claim.
2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
Where it participates (unsigned role)
Using acetaminophen as a probe, at low concentrations it is converted in a cooxidation reaction with arachidonic acid to the dimer 4,4-dihydroxy-3,3-biacetanilide and other polymeric products, and the electrophilic metabolite N-acetyl-p-benzoquinone imine was detected directly and indirectly by its reaction with glutathione to form 3-S-glutathionylacetaminophen; the same products were formed by the synthase with hydrogen peroxide in reactions not inhibited by indomethacin, and formation of all products was inhibited by ascorbic acid and butylated hydroxyanisole.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/paracetamol-research/3124965.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "dcc85a1ab66984973092042b5553f43fbbe5eb10b674614c9b1fa991b3969502", "start_char": 0, "end_char": 2236, "text_sha256": "dcc85a1ab66984973092042b5553f43fbbe5eb10b674614c9b1fa991b3969502"}
- experimental_model
- Ram seminal vesicle microsomal prostaglandin H synthase with product identification by cooxidation
- exposure
- Acetaminophen from 20 micromolar to above 10 millimolar, with glutathione, ascorbate and indomethacin
- limitations
- Shows that the drug both stimulates and inhibits the same enzyme depending on concentration, and that the enzyme makes NAPQI from it. A microsomal preparation at concentrations far above therapeutic.
- nutrient_topic
- Paracetamol research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from the metabolites NAPQI and AM404. · Paracetamol
- organism
- Sheep
- plain_language
- The prostaglandin enzyme can itself turn the drug into the liver-damaging metabolite.
- primary_references
- [apap-p3124965] Acetaminophen and analogs as cosubstrates and inhibitors of prostaglandin H synthase. (1988). https://pubmed.ncbi.nlm.nih.gov/3124965/ DOI: 10.1016/0009-2797(88)90101-9
- tissue_or_cell_type
- Seminal vesicle microsomes
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Ram seminal vesicle microsomal prostaglandin H synthase with product identification by cooxidation · source_derived_draft · unverified_draft
### apap-the-enzyme-makes-napqi Using acetaminophen as a probe, at low concentrations it is converted in a cooxidation reaction with arachidonic acid to the dimer 4,4-dihydroxy-3,3-biacetanilide and other polymeric products, and the electrophilic metabolite N-acetyl-p-benzoquinone imine was detected directly and indirectly by its reaction with glutathione to form 3-S-glutathionylacetaminophen; the same products were formed by the synthase with hydrogen peroxide in reactions not inhibited by indomethacin, and formation of all products was inhibited by ascorbic acid and butylated hydroxyanisole. Condition category: normal nutrient_topic: Paracetamol research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from the metabolites NAPQI and AM404. plain_language: The prostaglandin enzyme can itself turn the drug into the liver-damaging metabolite. organism: Sheep tissue_or_cell_type: Seminal vesicle microsomes experimental_model: Ram seminal vesicle microsomal prostaglandin H synthase with product identification by cooxidation limitations: Shows that the drug both stimulates and inhibits the same enzyme depending on concentration, and that the enzyme makes NAPQI from it. A microsomal preparation at concentrations far above therapeutic. exposure: Acetaminophen from 20 micromolar to above 10 millimolar, with glutathione, ascorbate and indomethacin evidence_span: {"source_cache": "artifacts/paracetamol-research/3124965.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "dcc85a1ab66984973092042b5553f43fbbe5eb10b674614c9b1fa991b3969502", "start_char": 0, "end_char": 2236, "text_sha256": "dcc85a1ab66984973092042b5553f43fbbe5eb10b674614c9b1fa991b3969502"} [apap-p3124965] Acetaminophen and analogs as cosubstrates and inhibitors of prostaglandin H synthase. (1988). https://pubmed.ncbi.nlm.nih.gov/3124965/ DOI: 10.1016/0009-2797(88)90101-9
Complete structured claim and evidenceAdding GSH decreased covalent microsomal protein binding while forming 3-S-glutathionylacetaminophen.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/glutathione-research/6424115.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8c45563e89388d200eb64ae63d12b388ef5cca91369a585157ef27b39f525b08", "start_char": 0, "end_char": 1307, "text_sha256": "8c45563e89388d200eb64ae63d12b388ef5cca91369a585157ef27b39f525b08"}
- experimental_model
- Enzyme oxidation and radiolabeled binding assays
- exposure
- NAPQI or acetaminophen with reductants
- limitations
- Experimental chemistry; no new human dose threshold or treatment regimen is inferred.
- nutrient_topic
- Glutathione research collection; topical membership is not evidence of a direct dietary effect. · GSH
- organism
- Mouse microsomes and cell-free cytochrome-P450 system
- plain_language
- Glutathione diverted the reactive metabolite into a conjugate.
- primary_references
- [glutathione-p6424115] N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. (1984). https://pubmed.ncbi.nlm.nih.gov/6424115/ DOI: 10.1073/pnas.81.5.1327
- tissue_or_cell_type
- Acetaminophen reactive-metabolite handling
Glutathione: metabolism, signaling and nutrient connections (2026-09-17) · lines 1035–1046
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Enzyme oxidation and radiolabeled binding assays · source_derived_draft · unverified_draft
### glutathione-napqi-conjugation Adding GSH decreased covalent microsomal protein binding while forming 3-S-glutathionylacetaminophen. Condition category: normal nutrient_topic: Glutathione research collection; topical membership is not evidence of a direct dietary effect. plain_language: Glutathione diverted the reactive metabolite into a conjugate. organism: Mouse microsomes and cell-free cytochrome-P450 system tissue_or_cell_type: Acetaminophen reactive-metabolite handling experimental_model: Enzyme oxidation and radiolabeled binding assays limitations: Experimental chemistry; no new human dose threshold or treatment regimen is inferred. exposure: NAPQI or acetaminophen with reductants evidence_span: {"source_cache": "artifacts/glutathione-research/6424115.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8c45563e89388d200eb64ae63d12b388ef5cca91369a585157ef27b39f525b08", "start_char": 0, "end_char": 1307, "text_sha256": "8c45563e89388d200eb64ae63d12b388ef5cca91369a585157ef27b39f525b08"} [glutathione-p6424115] N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. (1984). https://pubmed.ncbi.nlm.nih.gov/6424115/ DOI: 10.1073/pnas.81.5.1327
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.